•
Apr 30, 2020

Car-Mart Q4 2020 Earnings Report

America's Car-Mart reported diluted earnings per share of $1.35 on record revenues.

Key Takeaways

America's Car-Mart reported a strong Q4 performance with record revenues of $196 million and diluted earnings per share of $1.35, despite an $11.7 million pretax charge due to the COVID-19 pandemic. The company focused on customer service and adapted operations to the challenging environment.

Revenues reached a record $196 million.

Diluted earnings per share were reported at $1.35.

The company increased the allowance for credit losses due to the COVID-19 pandemic, resulting in an $11.7 million pre-tax charge.

Car-Mart focused on customer service and adapted operations during the pandemic, including launching curbside and home delivery processes.

Total Revenue
$196M
Previous year: $177M
+10.6%
EPS
$1.35
Previous year: $2.01
-32.8%
Net charge-offs
26.5%
Gross Profit
$93.4M
Previous year: $84.3M
+10.9%
Cash and Equivalents
$59.6M
Previous year: $1.75M
+3301.8%
Free Cash Flow
$18.8M
Previous year: $19.1M
-1.7%
Total Assets
$667M
Previous year: $493M
+35.5%

Car-Mart

Car-Mart

Forward Guidance

The company anticipates that disruptions in the consumer credit markets and in vehicle supply channels will present positive opportunities for the business.

Positive Outlook

  • Investing in the business, including recruiting, training, and retention of quality associates.
  • Improving operations, with significant emphasis on vehicle inventory.
  • Delivering an exceptional customer experience.
  • Significant opportunities to gain market share from existing locations.
  • New lot openings and strategic acquisitions are expected to be part of the plan moving forward.

Challenges Ahead

  • Uncertainty of how customers pay and react in this new environment.
  • COVID-19 has impacted customers and resulted in increased past-due amounts as a percentage of receivables.
  • Potential disruptions in the consumer credit markets.
  • Potential disruptions in vehicle supply channels.
  • Risk of exposure to the virus.